Investigating the role of specific brain neurons in diabetes and metabolism
Depleting Somatostatinergic Neurons Recapitulates Diabetic Phenotypes In Brain and Adipose Tissue
This study is looking at how changes in specific brain cells might affect diabetes and metabolism, with the hope of finding new ways to treat these conditions by understanding the link between brain inflammation and how our bodies manage fat and sugar.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10849913 on NIH RePORTER |
What this research studies
This research focuses on understanding how depleting certain neurons in the brain affects diabetes and metabolic syndrome. The study examines the relationship between brain inflammation and metabolic regulation, particularly in the hypothalamus, which is crucial for controlling body metabolism. By using animal models, the researchers aim to explore how these changes in the brain can lead to impaired fat metabolism and glucose regulation, potentially paving the way for new treatments that target brain inflammation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from type 2 diabetes or metabolic syndrome.
Not a fit: Patients with other forms of diabetes or those without metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that improve metabolic health and glucose control in patients with diabetes.
How similar studies have performed: While the specific approach of targeting somatostatinergic neurons is novel, related research has shown that addressing brain inflammation can impact metabolic conditions positively.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Rosencrans, Robert F — University of Alabama at Birmingham
- Study coordinator: Rosencrans, Robert F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.